ArticleAdvanced pharmaceutical bulletin2022

Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin.

Bahareh Hakiminia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.